Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Schott, Anne F
1066  Ergebnisse:
Personensuche X
?
1

Investigating potential disparities in clinical trial eligi..:

Patel, Monica A. ; Shah, Jennifer L. ; Brinley IV, Floyd John...
Cancer Medicine.  12 (2023)  11 - p. 12802-12812 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Envisioning clinical trials as complex interventions:

Stensland, Kristian D. ; Damschroder, Laura J. ; Sales, Anne E...
Cancer.  128 (2022)  17 - p. 3145-3151 , 2022
Link: https://doi.org/10.1002/..
 
?
3

Improving the delivery of team-based survivorship care afte..:

Wallner, Lauren P. ; Abrahamse, Paul ; Gargaro, Joan G....
Breast Cancer Research and Treatment.  189 (2021)  1 - p. 81-92 , 2021
Link: https://doi.org/10.1007/..
 
?
4

A randomized, placebo-controlled phase 2 study of paclitaxe..:

Goldstein, Lori J. ; Mansutti, Mauro ; Levy, Christelle...
Breast Cancer Research and Treatment.  190 (2021)  2 - p. 265-275 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Factors influencing the use of extended adjuvant endocrine ..:

Kadakia, Kunal C. ; Kidwell, Kelley M. ; Barton, Debra L....
Breast Cancer Research and Treatment.  175 (2019)  1 - p. 181-189 , 2019
Link: https://doi.org/10.1007/..
 
?
6

Association between body mass index and response to duloxet..:

Henry, N. Lynn ; Unger, Joseph M. ; Till, Cathee...
Cancer.  125 (2019)  12 - p. 2123-2129 , 2019
Link: https://doi.org/10.1002/..
 
?
7

Clinical predictors of long-term survival in HER2-positive ..:

Murthy, Pooja ; Kidwell, Kelley M. ; Schott, Anne F....
Breast Cancer Research and Treatment.  155 (2016)  3 - p. 589-595 , 2016
Link: https://doi.org/10.1007/..
 
?
8

Phase II studies of two different schedules of dasatinib in..:

Schott, Anne F. ; Barlow, William E. ; Van Poznak, Catherine H....
Breast Cancer Research and Treatment.  159 (2016)  1 - p. 87-95 , 2016
Link: https://doi.org/10.1007/..
 
?
9

Heterogeneous estrogen receptor expression in circulating t..:

Paoletti, Costanza ; Larios, Jose M. ; Muñiz, Maria C....
Molecular Oncology.  10 (2016)  7 - p. 1078-1085 , 2016
Link: https://doi.org/10.1016/..
 
?
10

Multi-Site Clinical Evaluation of DW-MRI as a Treatment Res..:

Galbán, Craig J. ; Ma, Bing ; Malyarenko, Dariya...
PLOS ONE.  10 (2015)  3 - p. e0122151 , 2015
Link: https://doi.org/10.1371/..
 
?
11

Image Registration for Quantitative Parametric Response Map..:

Boes, Jennifer L. ; Hoff, Benjamin A. ; Hylton, Nola...
Translational Oncology.  7 (2014)  1 - p. 101-110 , 2014
Link: https://doi.org/10.1593/..
 
?
12

Effect of Estrogen Depletion on Pain Sensitivity in Aromata..:

Henry, N. Lynn ; Conlon, Anna ; Kidwell, Kelley M....
The Journal of Pain.  15 (2014)  5 - p. 468-475 , 2014
Link: https://doi.org/10.1016/..
 
?
13

Activating ESR1 mutations in hormone-resistant metastatic b..:

Robinson, Dan R ; Wu, Yi-Mi ; Vats, Pankaj...
Nature Genetics.  45 (2013)  12 - p. 1446-1451 , 2013
Link: https://doi.org/10.1038/..
 
?
14

Prediction of Postchemotherapy Ovarian Function Using Marke..:

Henry, N. Lynn ; Xia, Rong ; Schott, Anne F....
The Oncologist.  19 (2013)  1 - p. 68-74 , 2013
Link: https://doi.org/10.1634/..
 
?
15

Phase II Trial of Simple Oral Therapy with Capecitabine and..:

Schott, Anne F. ; Barlow, William E. ; Albain, Kathy S....
The Oncologist.  17 (2012)  2 - p. 179-187 , 2012
Link: https://doi.org/10.1634/..
 
1-15